5002882026-04-012026-06-305002882026-04-012026-06-30in-capmkt:OtherExpenses1Member5002882026-04-012026-06-30in-capmkt:OtherExpenses2Member5002882026-04-012026-06-30in-capmkt:OtherExpenses3Member5002882026-04-012026-06-30in-capmkt:OtherExpenses4Member5002882026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15002882026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares500288MOREPENLABNOTLISTEDINE083A01026MOREPEN LABORATORIES LIMITEDMain BoardEquity2026-04-012027-03-312026-08-042026-07-28INRLakhsQuarterlyFirst quarterSingle segmentPharmaceuticals2026-08-0411:30:002026-08-0413:20:00Not applicable2026-04-012026-06-30UnauditedConsolidated5701281000518340005753115000328380500096409000-1931790006244350004841300083488000106447000050078410007452740000745274000181885000-69000181816000056345800000053600056399400019010005658950000000109584100021.031.03001.031.031.The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 4, 2026. A Limited review of the same has been carried out by the Statutory Auditors. <br /> 2. 'The figures for the quarter ended March 31, 2026 are the balancing figures between audited figures in respect of the full financial year and the unaudited published year to date figures upto the third quarter ended December 31, 2025. <br /> 3.The Company is engaged in the Pharmaceutical Business Segment. <br /> <br /> <br /> Sl. Name of the Entity Status % holding Held by Morepen Laboratories Ltd. through <br /> <br /> 1 Morepen Laboratories Ltd. Holding Company Parent Co. Parent Company <br /> <br /> 2 Morepen Rx Ltd. Wholly Owned Subsidiary 100% Morepen Laboratories Ltd. <br /> <br /> 3 Morepen Devices Ltd. Wholly Owned Subsidiary 100% Morepen Laboratories Ltd. <br /> <br /> 4 Morepen Bio Inc., USA Wholly Owned Subsidiary 100% Morepen Laboratories Ltd. <br /> <br /> 5 Morepen Labs -FZE, Dubai Wholly Owned Subsidiary 100% Morepen Laboratories Ltd. <br /> (Formely Morepen Labs- FZCO, Dubai) <br /> <br /> 6 Morepen Medipath Limited Subsidiary 51% Morepen Laboratories Ltd. <br /> (Formerly Morepen Medtech Limited) <br /> <br /> 7 Morepen Medical Equipment Trading L.L.C, Dubai Subsidiary 51% Morepen Medipath Ltd. <br /> <br /> 8 Sigmacheck Health Private Limited Subsidiary 51% Morepen Medipath Ltd. <br /> Power and Fuel128067000Travelling Expenses56466000Selling and Distribution Expenses533143000Other Expenses346794000Re-measurement gain on Defined Benefit Plans2323000Income tax relating to items that will not be reclassified to profit or loss-4220001901000001901000